Spectrum Pharmaceuticals (SPPI) Q4 2021 Earnings Call Transcript
SPPI earnings call for the period ending December 31, 2021.
Source: fool.com
Stay updated with breaking news from Tom Riga. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SPPI earnings call for the period ending December 31, 2021.
The FDA has accepted for review the NDA for poziotinib for previously treated locally advanced or metastatic NSCLC with HER2 exon 20 insertion mutations.
Tom Riga named President and Chief Executive Officer and will join the Board of Directors effective December 31, 2021Joe Turgeon, President and Chief Executive Officer, to retire and step down from Board of DirectorsHENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutica...